Due to the increasing demand for vision and spectacle independence among patients, as well as technological advancements, premium intraocular lenses (IOLs), including presbyopia correction IOLs and astigmatism correction IOLs, are increasingly being adopted in clinical practice. Existing studies have shown that some glaucoma patients implanted with premium IOLs have a high rate of spectacle independence, excellent visual acuity, and comparable contrast sensitivity to healthy subjects, with high postoperative patient satisfaction. However, there is currently a lack of sufficient evidence to support the safety ofpremium IOL implantation in patients with advanced glaucoma. When combining cataract extraction surgery with certain glaucoma surgeries, premium IOLs should be carefully selected, as there may be other intraoperative and postoperative factors that affect the visual quality after surgery. Premium IOL often has better results in suspected glaucoma patients, patients with high intraocular pressure, and glaucoma patients with good early disease control. The selection of IOL should be comprehensively considered based on the patient's expected refractive outcome, glaucoma subtypes, the type and severity of glaucoma visual field defects, and the type of glaucoma surgery.
(Int Rev Ophthalmol, 2024, 48: 1-7)
